Development of Emerging Disease Agent Biologics

Comment on this policy

Although the AVMA recognizes the need to protect intellectual property, the failure of researchers to share isolates of emerging agents with other investigators has the potential of adversely impacting animal health and well being by delaying disease research and the development of diagnostic modalities and preventive measures such as vaccines. The AVMA encourages cooperation between researchers, biotechnology and animal health industries, and regulatory agencies for the promotion of animal health.

AVMA Products:

Veterinary Biologics Brochure (Download PDF